India Pharmas Increase Prices Of Uncontrolled Drugs To Offset Controls
This article was originally published in PharmAsia News
Executive Summary
India drug makers have been quietly increasing the prices of products that fall outside the purview of the National Pharmaceutical Pricing Authority to maintain growth in the face of government price cuts.